ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,882Medicare Part D Prescriptions Filled, Including Refills

Rank: 75 out of 1290

$393K Total Retail Price of All Prescriptions

Rank: 264 out of 1290

354 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 354 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

8% of this provider’s 354 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

4% of this provider’s 6,719 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
FUROSEMIDE 479 381 1 9
TRAMADOL HCL 278 170 2 25
METFORMIN HCL 264 172 3 10
AMLODIPINE BESYLATE 250 203 4 3
LEVOTHYROXINE SODIUM 248 211 5 4
TRAZODONE HCL 234 160 6 44
METOPROLOL TARTRATE 225 193 7 7
GLYBURIDE 197 135 R 8 87
SIMVASTATIN 190 164 9 1
ATENOLOL 181 148 10 18
HYDROCHLOROTHIAZIDE 178 137 11 20
RANITIDINE HCL 176 102 12 49
LOVASTATIN 173 113 13 45
GABAPENTIN 157 63 14 8
ENALAPRIL MALEATE 130 78 15 62
GLIPIZIDE 128 83 16 81
CLOPIDOGREL 124 80 17 24
LISINOPRIL 122 101 18 5
OMEPRAZOLE 113 75 19 2
DIGOXIN 104 77 20 51
BUSPIRONE HCL 104 75 20 178
PLAVIX 100 83 22 32
ALPRAZOLAM 98 78 23 47
ACETAMINOPHEN-CODEINE 97 37 S3 24 138
PROAIR HFA 91 51 25 73
IBUPROFEN 87 76 26 74
CITALOPRAM HBR 86 68 27 29
RISPERIDONE 85 43 28 68
NOVOLIN 70-30 85 36 28 233
FAMOTIDINE 81 45 30 128
DIVALPROEX SODIUM 80 45 31 121
ALLOPURINOL 79 78 32 60
CARVEDILOL 76 48 33 12
PREDNISONE 75 53 34 21
ALENDRONATE SODIUM 74 60 35 39
BENZTROPINE MESYLATE 73 43 R 36 108
PROPRANOLOL HCL 73 62 36 242
AMOXICILLIN 69 46 38 227
METOLAZONE 66 64 39 358
SERTRALINE HCL 66 48 39 36
WARFARIN SODIUM 65 56 41 22
LACTULOSE 62 36 42 254
MEGESTROL ACETATE 61 54 R 43 198
NOVOLIN R 61 31 43 303
DOXAZOSIN MESYLATE 60 42 45 64
POTASSIUM CHLORIDE 59 46 46 35
HYDROCODONE-ACETAMINOPHEN 58 48 S3 47 6
DIOVAN 56 56 48 53
LORAZEPAM 56 56 48 132
NIFEDIPINE ER 56 43 48 110
ZOLPIDEM TARTRATE 54 45 51 15
METOPROLOL SUCCINATE 52 26 52 14
CLONIDINE HCL 52 27 52 66
PRIMIDONE 51 33 54 127
RAMIPRIL 51 48 54 136
FLUOXETINE HCL 50 21 56 79
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 2, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.